JP2024516356A5 - - Google Patents
Info
- Publication number
- JP2024516356A5 JP2024516356A5 JP2023562314A JP2023562314A JP2024516356A5 JP 2024516356 A5 JP2024516356 A5 JP 2024516356A5 JP 2023562314 A JP2023562314 A JP 2023562314A JP 2023562314 A JP2023562314 A JP 2023562314A JP 2024516356 A5 JP2024516356 A5 JP 2024516356A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense strand
- double
- seq
- khk
- sense strand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163173775P | 2021-04-12 | 2021-04-12 | |
| US63/173,775 | 2021-04-12 | ||
| US202163182277P | 2021-04-30 | 2021-04-30 | |
| US63/182,277 | 2021-04-30 | ||
| EP21196784 | 2021-09-15 | ||
| EP21196784.9 | 2021-09-15 | ||
| PCT/EP2022/059663 WO2022218941A2 (en) | 2021-04-12 | 2022-04-11 | Compositions and methods for inhibiting ketohexokinase (khk) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516356A JP2024516356A (ja) | 2024-04-15 |
| JP2024516356A5 true JP2024516356A5 (enExample) | 2025-04-22 |
Family
ID=81448852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562314A Abandoned JP2024516356A (ja) | 2021-04-12 | 2022-04-11 | ケトヘキソキナーゼ（ｋｈｋ）を阻害するための組成物及び方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20220340909A1 (enExample) |
| EP (1) | EP4323518A2 (enExample) |
| JP (1) | JP2024516356A (enExample) |
| KR (1) | KR20230170732A (enExample) |
| CN (1) | CN117120612A (enExample) |
| AU (1) | AU2022256742A1 (enExample) |
| BR (1) | BR112023017367A2 (enExample) |
| CA (1) | CA3214439A1 (enExample) |
| CL (1) | CL2023003017A1 (enExample) |
| CO (1) | CO2023013465A2 (enExample) |
| CR (1) | CR20230482A (enExample) |
| DO (1) | DOP2023000223A (enExample) |
| EC (1) | ECSP23076906A (enExample) |
| IL (1) | IL307315A (enExample) |
| JO (1) | JOP20230250A1 (enExample) |
| MX (1) | MX2023012048A (enExample) |
| PE (1) | PE20250400A1 (enExample) |
| PH (1) | PH12023552830A1 (enExample) |
| TW (1) | TW202305135A (enExample) |
| WO (1) | WO2022218941A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3211059A1 (en) * | 2021-02-26 | 2022-09-01 | Alnylam Pharmaceuticals, Inc. | Ketohexokinase (khk) irna compositions and methods of use thereof |
| TW202430191A (zh) | 2022-10-11 | 2024-08-01 | 德商百靈佳殷格翰國際股份有限公司 | 用於治療伴有晚期纖維化及/或硬化之nash的方法 |
| TW202430192A (zh) | 2022-10-11 | 2024-08-01 | 德商百靈佳殷格翰國際股份有限公司 | 用於治療nash之劑量方案 |
| WO2024175062A1 (zh) * | 2023-02-23 | 2024-08-29 | 大睿生物医药科技(上海)有限公司 | 调控KHK基因活性的dsRNA分子 |
| WO2024260379A1 (zh) * | 2023-06-20 | 2024-12-26 | 施能康医药科技(苏州)有限公司 | 靶向已酮糖激酶的核酸及其用途 |
| CN118703500B (zh) * | 2024-01-30 | 2025-06-17 | 大连医科大学 | 一种果糖激酶khk的小干扰和短发夹rna序列组合及其应用 |
| WO2025184876A1 (zh) * | 2024-03-07 | 2025-09-12 | 竣莅医药科技（无锡）有限公司 | 一种rna干扰触发分子与对应核酸干扰药物制剂及其用途 |
| WO2026149467A1 (zh) * | 2025-01-09 | 2026-07-16 | 云合智药（苏州）生物科技有限公司 | 用于抑制己酮糖激酶表达的RNAi剂及其应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469158B1 (en) | 1992-05-14 | 2002-10-22 | Ribozyme Pharmaceuticals, Incorporated | Synthesis, deprotection, analysis and purification of RNA and ribozymes |
| US5977343A (en) | 1992-05-14 | 1999-11-02 | Ribozyme Pharmaceuticals, Inc. | Synthesis, deprotection, analysis and purification of RNA and ribozymes |
| US5804683A (en) | 1992-05-14 | 1998-09-08 | Ribozyme Pharmaceuticals, Inc. | Deprotection of RNA with alkylamine |
| EP1253199A1 (en) | 1993-09-02 | 2002-10-30 | Ribozyme Pharmaceuticals, Inc. | Abasic moieties containing enzymatic nucleic acids |
| US5889136A (en) | 1995-06-09 | 1999-03-30 | The Regents Of The University Of Colorado | Orthoester protecting groups in RNA synthesis |
| US5998203A (en) | 1996-04-16 | 1999-12-07 | Ribozyme Pharmaceuticals, Inc. | Enzymatic nucleic acids containing 5'-and/or 3'-cap structures |
| US6111086A (en) | 1998-02-27 | 2000-08-29 | Scaringe; Stephen A. | Orthoester protecting groups |
| KR20080023768A (ko) | 2000-03-30 | 2008-03-14 | 화이트헤드 인스티튜트 포 바이오메디칼 리서치 | Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체 |
| CN100523215C (zh) | 2000-12-01 | 2009-08-05 | 马普科技促进协会 | 介导rna干涉的小rna分子 |
| US20050159378A1 (en) | 2001-05-18 | 2005-07-21 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA) |
| WO2003040395A2 (en) | 2001-11-07 | 2003-05-15 | Applera Corporation | Universal nucleotides for nucleic acid analysis |
| US20070265220A1 (en) | 2004-03-15 | 2007-11-15 | City Of Hope | Methods and compositions for the specific inhibition of gene expression by double-stranded RNA |
| WO2007030167A1 (en) | 2005-09-02 | 2007-03-15 | Nastech Pharmaceutical Company Inc. | Modification of double-stranded ribonucleic acid molecules |
| WO2010033225A2 (en) | 2008-09-22 | 2010-03-25 | Dicerna Pharmaceuticals, Inc. | Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications |
| KR20110110776A (ko) | 2008-12-18 | 2011-10-07 | 다이서나 파마수이티컬, 인크. | 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법 |
| WO2010093788A2 (en) | 2009-02-11 | 2010-08-19 | Dicerna Pharmaceuticals, Inc. | Multiplex dicer substrate rna interference molecules having joining sequences |
| US8927513B2 (en) | 2009-07-07 | 2015-01-06 | Alnylam Pharmaceuticals, Inc. | 5′ phosphate mimics |
| US9725479B2 (en) | 2010-04-22 | 2017-08-08 | Ionis Pharmaceuticals, Inc. | 5′-end derivatives |
| AU2012328680A1 (en) | 2011-10-25 | 2014-05-01 | Ionis Pharmaceuticals, Inc. | Antisense modulation of GCCR expression |
| EP3105331B1 (en) * | 2014-02-11 | 2021-06-23 | Alnylam Pharmaceuticals, Inc. | Ketohexokinase (khk) irna compositions and methods of use thereof |
| US10351854B2 (en) * | 2014-10-10 | 2019-07-16 | Dicerna Pharmaceuticals, Inc. | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
| EP3865576A1 (en) * | 2014-12-15 | 2021-08-18 | Dicerna Pharmaceuticals, Inc. | Ligand-modified double-stranded nucleic acids |
| WO2018045317A1 (en) * | 2016-09-02 | 2018-03-08 | Dicerna Pharmaceuticals, Inc. | 4'-phosphate analogs and oligonucleotides comprising the same |
| EP3684377B1 (en) * | 2017-10-20 | 2022-12-07 | Dicerna Pharmaceuticals, Inc. | Methods for treating hepatitis b infection |
| JP2022500003A (ja) * | 2018-09-18 | 2022-01-04 | アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. | ケトヘキソキナーゼ（ＫＨＫ）ｉＲＮＡ組成物およびその使用方法 |
| US20220389430A1 (en) * | 2019-10-02 | 2022-12-08 | Dicema Pharmaceuticals, Inc. | Chemical modifications of small interfering rna with minimal fluorine content |
| MX2022011009A (es) * | 2020-03-06 | 2022-10-07 | Alnylam Pharmaceuticals Inc | Composiciones de acido ribonucleico de interferencia (arni) de ketohexocinasa (khk) y metodos de uso de las mismas. |
| CA3211059A1 (en) * | 2021-02-26 | 2022-09-01 | Alnylam Pharmaceuticals, Inc. | Ketohexokinase (khk) irna compositions and methods of use thereof |
-
2022
- 2022-04-11 MX MX2023012048A patent/MX2023012048A/es unknown
- 2022-04-11 WO PCT/EP2022/059663 patent/WO2022218941A2/en not_active Ceased
- 2022-04-11 CN CN202280027703.6A patent/CN117120612A/zh active Pending
- 2022-04-11 TW TW111113704A patent/TW202305135A/zh unknown
- 2022-04-11 PE PE2023002847A patent/PE20250400A1/es unknown
- 2022-04-11 EP EP22719944.5A patent/EP4323518A2/en not_active Withdrawn
- 2022-04-11 JP JP2023562314A patent/JP2024516356A/ja not_active Abandoned
- 2022-04-11 PH PH1/2023/552830A patent/PH12023552830A1/en unknown
- 2022-04-11 CR CR20230482A patent/CR20230482A/es unknown
- 2022-04-11 KR KR1020237038934A patent/KR20230170732A/ko active Pending
- 2022-04-11 AU AU2022256742A patent/AU2022256742A1/en not_active Withdrawn
- 2022-04-11 BR BR112023017367A patent/BR112023017367A2/pt not_active Application Discontinuation
- 2022-04-11 CA CA3214439A patent/CA3214439A1/en active Pending
- 2022-04-11 US US17/717,174 patent/US20220340909A1/en not_active Abandoned
- 2022-04-11 IL IL307315A patent/IL307315A/en unknown
-
2023
- 2023-10-10 CL CL2023003017A patent/CL2023003017A1/es unknown
- 2023-10-11 EC ECSENADI202376906A patent/ECSP23076906A/es unknown
- 2023-10-11 CO CONC2023/0013465A patent/CO2023013465A2/es unknown
- 2023-10-11 DO DO2023000223A patent/DOP2023000223A/es unknown
- 2023-10-12 JO JOJO/P/2023/0250A patent/JOP20230250A1/ar unknown
-
2024
- 2024-04-22 US US18/641,868 patent/US20250092403A1/en active Pending